Aplagon secures EUR 7 million for APAC phase 2a trials - PharmaTimes Funding led by new investors FSG and EIC Fund

#Aplagon #APACtherapeutic #thromboinflammatorydiseases #heparinproteoglycanmimetic #antiplatelet #anticoagulant #mastcellderivedheparinproteoglycans #antithrombotic #antiinflammatory #peripheralarterialocclusivedisease #chroniclimbthreateningischemia #PAOD #CLTI
pharmatimes.com/news/aplagon...

Finnish biotech company secures €7 million to advance APAC therapy for thrombo-inflammatory diseases - ArcticStartup Aplagon, a Helsinki-based clinical-stage biopharmaceutical company focused on thrombo-inflammatory diseases, has closed a €7 million funding round led by

#helyes #Aplagon, a clinical-stage biopharmaceutical company focused on thrombo-inflammatory diseases, has closed a €7M funding round led by Fåhraeus Startup and Growth (FSG) and the European Innovation Council (@EUeic) Fund. By @arcticstartup
arcticstartup.com/aplagon-rais... #NordicMade